{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:37:19Z","timestamp":1792427839456,"version":"4.5.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["120217720"],"award-info":[{"award-number":["120217720"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Hum. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Most patients with new-onset refractory status epilepticus (NORSE) subsequently develop drug-resistant epilepsy (DRE) with multiple seizure foci and are not the typical candidates for resective surgery. We report the first case of DRE developing after cryptogenic-NORSE (C-NORSE) that was successfully treated using deep brain stimulation targeting the anterior nucleus of the thalamus (ANT-DBS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 52-year-old man developed C-NORSE at the age of 45\u2009years and presented with sequelae of DRE and cognitive dysfunction despite anti-seizure medications and immunotherapy administration. Seizure semiology comprised palpitations, chills, and nausea, followed by impairment of awareness with oral automatism multiple times a day. Video-electroencephalogram monitoring (vEEG) showed bilateral independent electrographic seizures (ESz) in the fronto-temporal areas. He underwent ANT-DBS. Preoperative and postoperative vEEG recordings for 3\u2009days were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Preoperative vEEG showed 11 clinical seizures correlated with ESz. The duration of ESz ranged from 55 to 213\u2009s (median, 81\u2009s). Three months after ANT-DBS stimulation, vEEG showed four subclinical ESz episodes lasting from 22 to 31\u2009s (median, 25.5\u2009s) (Mann\u2013Whitney\n                      <jats:italic>U<\/jats:italic>\n                      test,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). The patient had not developed an overt clinical seizure until the last follow-up at 9\u2009months. No adverse events were observed during treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ANT-DBS is an effective treatment option for DRE after NORSE, particularly when the epileptogenic network is located in the temporal lobe. A detailed evaluation using vEEG is useful for identifying the epileptogenic foci and assessing therapeutic outcome. Immunomodulatory mechanisms via cytokines could play roles in the pathogenesis of development of DRE after NORSE and seizure suppression effect of ANT-DBS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnhum.2025.1663280","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:11:41Z","timestamp":1761916301000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Deep brain stimulation of the anterior nucleus of the thalamus for seizures after new-onset refractory status epilepticus: a case report"],"prefix":"10.3389","volume":"19","author":[{"given":"Ryota","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"13765","DOI":"10.1038\/s41598-021-93265-x","article-title":"A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy","volume":"11","author":"Basnyat","year":"2021","journal-title":"Sci. Rep."},{"key":"ref2","article-title":"New onset refractory status epilepticus","volume-title":"StatPearls","author":"Bhatia","year":"2025"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1528-1167.2010.02536.x","article-title":"Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy","volume":"51","author":"Fisher","year":"2010","journal-title":"Epilepsia"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yebeh.2017.01.032","article-title":"Patient emotions and perceptions of antiepileptic drug changes and titration during treatment for epilepsy","volume":"69","author":"Fishman","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus: etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1474-4422(24)00430-7","article-title":"Diagnosis and management of status epilepticus: improving the status quo","volume":"24","author":"Gettings","year":"2025","journal-title":"Lancet Neurol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/epi4.12568","article-title":"Deep brain stimulation of the centromedian thalamic nucleus for the treatment of FIRES","volume":"7","author":"Hect","year":"2022","journal-title":"Epilepsia Open"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","article-title":"American Clinical Neurophysiology Society\u2019s standardized critical care EEG terminology: 2021 version","volume":"38","author":"Hirsch","year":"2021","journal-title":"J. Clin. Neurophysiol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.seizure.2019.08.015","article-title":"Anticonvulsive effect of anterior thalamic deep brain stimulation in super-refractory status epilepticus crucially depends on active stimulation zone\u2014a single case observation","volume":"71","author":"Imbach","year":"2019","journal-title":"Seizure"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.yebeh.2018.09.006","article-title":"Reversible psychiatric adverse effects related to deep brain stimulation of the anterior thalamus in patients with refractory epilepsy","volume":"88","author":"J\u00e4rvenp\u00e4\u00e4","year":"2018","journal-title":"Epilepsy Behav."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"109918","DOI":"10.1016\/j.yebeh.2024.109918","article-title":"Mortality and morbidity of status epilepticus over the long term","volume":"158","author":"K\u00e4mppi","year":"2024","journal-title":"Epilepsy Behav."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1111\/j.1528-1167.2011.03250.x","article-title":"Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children","volume":"52","author":"Kramer","year":"2011","journal-title":"Epilepsia"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/epi.17912","article-title":"The risk of unprovoked seizure occurrence after status epilepticus in adults","volume":"65","author":"Lattanzi","year":"2024","journal-title":"Epilepsia"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.wneu.2016.11.097","article-title":"Successful treatment of refractory status epilepticus using anterior thalamic nuclei deep brain stimulation","volume":"99","author":"Lee","year":"2017","journal-title":"World Neurosurg."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/ana.24821","article-title":"Successful management of super-refractory status epilepticus with thalamic deep brain stimulation","volume":"81","author":"Lehtim\u00e4ki","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1172898","DOI":"10.3389\/fneur.2023.1172898","article-title":"Perspective: Vagal nerve stimulation in the treatment of new-onset refractory status epilepticus","volume":"14","author":"Mantoan Ritter","year":"2023","journal-title":"Front. Neurol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.seizure.2011.12.003","article-title":"Cognitive improvement after long-term electrical stimulation of bilateral anterior thalamic nucleus in refractory epilepsy patients","volume":"21","author":"Oh","year":"2012","journal-title":"Seizure"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.clinph.2024.03.032","article-title":"Responsive neurostimulation as a therapy for epilepsy following new-onset refractory status epilepticus: case series and review of the literature","volume":"162","author":"Oliger","year":"2024","journal-title":"Clin. Neurophysiol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ejpn.2019.08.001","article-title":"Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES\u2014two different outcomes","volume":"23","author":"Sa","year":"2019","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1136\/jnnp-2014-309388","article-title":"Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus","volume":"86","author":"Sakuma","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/epi.16895","article-title":"The SANT\u00c9 study at 10 years of follow-up: effectiveness, safety, and sudden unexpected death in epilepsy","volume":"62","author":"Salanova","year":"2021","journal-title":"Epilepsia"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.seizure.2020.07.022","article-title":"Deep brain stimulation for the treatment of refractory and super-refractory status epilepticus","volume":"81","author":"Sobstyl","year":"2020","journal-title":"Seizure"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1195844","DOI":"10.3389\/fneur.2023","article-title":"Neuromodulation in new-onset refractory status epilepticus","volume":"14","author":"Stavropoulos","year":"2023","journal-title":"Front. Neurol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.brs.2020.12.013","article-title":"Low frequency centromedian thalamic nuclei deep brain stimulation for the treatment of super refractory status epilepticus: a case report and a review of the literature","volume":"14","author":"Stavropoulos","year":"2021","journal-title":"Brain Stimul."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/brain\/awn218","article-title":"Improved cerebral function in mesial temporal lobe epilepsy after subtemporal amygdalohippocampectomy","volume":"132","author":"Takaya","year":"2009","journal-title":"Brain"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.brs.2011.10.002","article-title":"Centromedian thalamic nuclei deep brain stimulation in refractory status epilepticus","volume":"5","author":"Valent\u00edn","year":"2012","journal-title":"Brain Stimul."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.47102\/annals-acadmedsg.V34N7p417","article-title":"The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity","volume":"34","author":"Wilder-Smith","year":"2005","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1169105","DOI":"10.3389\/fneur.2023.1169105","article-title":"Deep brain stimulation for patients with refractory epilepsy: nuclei selection and surgical outcome","volume":"14","author":"Yan","year":"2023","journal-title":"Front. Neurol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1684\/epd.2019.1086","article-title":"Deep brain stimulation of the anterior nucleus of the thalamus in a patient with super-refractory convulsive status epilepticus","volume":"21","author":"Yuan","year":"2019","journal-title":"Epileptic Disord."}],"container-title":["Frontiers in Human Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2025.1663280\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:11:42Z","timestamp":1761916302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2025.1663280\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":31,"alternative-id":["10.3389\/fnhum.2025.1663280"],"URL":"https:\/\/doi.org\/10.3389\/fnhum.2025.1663280","relation":{},"ISSN":["1662-5161"],"issn-type":[{"value":"1662-5161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"1663280"}}